Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry’s Controlling Hand in Health Reform Debate, According to Consumer Watchdog
<p>
WASHINGTON, D.C. -- The failure of the U.S. Senate to allow importation
of prescription drugs to cut costs, much less the more effective direct
bulk purchasing of prescription drugs, is just the latest example of
how big industry controls the health reform debate, according Consumer
Watchdog.
</p>
